This question was posed to our readers based on the information presented in the recent news article, Updated Clinical Practice Guideline for Managing Community-Acquired Pneumonia.
Per the guidelines published in the Annals of the American Thoracic Society, the panel recommended that anti-influenza therapies (eg, oseltamivir) be used to treat adults with community-acquired pneumonia who test positive for influenza regardless of the illness duration prior to diagnosis in both inpatient and outpatient settings.
Jones BE, Herman DD, Dela Cruz CS, et al. Summary for clinicians: clinical practice guideline for the diagnosis and treatment of community-acquired pneumonia [published online November 26, 2019]. Ann Am Thorac Soc. doi:10.1513/AnnalsATS.201909-704CME